We are live on ! Find out more
Boston Trust Walden

Boston Trust Walden Portfolio holdings

AUM $13.1B Turnover 6.42%
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH icon
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.91%
2 Healthcare 16.24%
3 Technology 15.4%
4 Industrials 13.98%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VFC icon
301
VF Corp
VFC
$6.62B
$1.07M 0.02%
15,383
– –
2013 Q2
18 quarters
TD icon
302
Toronto Dominion Bank
TD
$197B
$1.06M 0.02%
18,083
+6,730
+59% +$384K
2017 Q2
2 quarters
DELL icon
303
Dell
DELL
$287B
$1.06M 0.02%
46,286
-852
-2% -$19.3K
2016 Q3
5 quarters
BAC icon
304
Bank of America
BAC
$358B
$991K 0.01%
33,554
+4,500
+15% +$124K
2013 Q4
16 quarters
VNQ icon
305
Vanguard Real Estate ETF
VNQ
$36.8B
$971K 0.01%
11,700
-500
-4% -$41.9K
2013 Q2
18 quarters
WEC icon
306
WEC Energy
WEC
$35.4B
$938K 0.01%
14,130
-75
-0.5% -$5.03K
2013 Q4
16 quarters
SPY icon
307
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$930K 0.01%
3,484
– –
2017 Q1
3 quarters
SPGI icon
308
S&P Global
SPGI
$127B
$913K 0.01%
5,388
-130
-2% -$21.2K
2017 Q2
2 quarters
BRK.A icon
309
Berkshire Hathaway Class A
BRK.A
$1.14T
$893K 0.01%
3
– –
2013 Q2
18 quarters
ROK icon
310
Rockwell Automation
ROK
$47.3B
$884K 0.01%
4,500
– –
2013 Q2
18 quarters
BIIB icon
311
Biogen
BIIB
$34.4B
$858K 0.01%
2,694
– –
2013 Q2
18 quarters
VEA icon
312
Vanguard FTSE Developed Markets ETF
VEA
$228B
$846K 0.01%
18,857
-667
-3% -$29.5K
2013 Q2
18 quarters
EWJ icon
313
iShares MSCI Japan ETF
EWJ
$23.1B
$811K 0.01%
13,537
-20,500
-60% -$1.2M
2013 Q2
18 quarters
IWD icon
314
iShares Russell 1000 Value ETF
IWD
$83.6B
$808K 0.01%
6,497
– –
2016 Q4
4 quarters
PH icon
315
Parker-Hannifin
PH
$121B
$783K 0.01%
3,925
– –
2013 Q2
18 quarters
NEE icon
316
NextEra Energy
NEE
$166B
$779K 0.01%
19,948
+2,760
+16% +$107K
2013 Q2
18 quarters
NSC icon
317
Norfolk Southern
NSC
$73.4B
$764K 0.01%
5,271
-20
-0.4% -$2.69K
2013 Q2
18 quarters
MA icon
318
Mastercard
MA
$541B
$753K 0.01%
4,977
-250
-5% -$37.2K
2013 Q3
17 quarters
IVV icon
319
iShares Core S&P 500 ETF
IVV
$880B
$725K 0.01%
2,698
-8
-0.3% -$2.1K
2016 Q1
7 quarters
VTV icon
320
Vanguard Morningstar Value ETF
VTV
$191B
$722K 0.01%
6,787
-124
-2% -$12.8K
2017 Q1
3 quarters
WMT icon
321
Walmart Inc
WMT
$943B
$694K 0.01%
21,078
+57
+0.3% +$1.74K
2013 Q2
18 quarters
LLY icon
322
Eli Lilly
LLY
$1.12T
$648K 0.01%
7,677
-260
-3% -$22.1K
2015 Q2
10 quarters
EPP icon
323
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
$626K 0.01%
13,100
-10,500
-44% -$496K
2013 Q2
18 quarters
K icon
324
DELISTED
Kellanova
K
$624K 0.01%
9,771
-54
-0.5% -$3.25K
2013 Q2
18 quarters
UL icon
325
Unilever
UL
$142B
$622K 0.01%
9,994
+3,716
+59% +$235K
2016 Q2
6 quarters
11 12
13
14 15

Similar funds

Markel Group
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Great Lakes Advisors
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
Van Lanschot Kempen Investment Management
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
Brinker Capital Investments
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EdgePoint Investment Group
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
Penserra Capital Management
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Westwood Holdings Group
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.